2Beeh K M, Kornmann O, Buhl R, et al. eutrophil chemotactic activity of sputum from patients with COPD: role of interleukin 8 and leukotriene B4 [ J]. Chest,2003, 123 : 1240.
3Biernacki W A, kharitonov S A, Barnes P J. Increased leukotrieneB4 and-8isoprostane in exhaled breath condensate of patients with acute exacerbation of COPD [J]. Thorax,2003,58:294.
3GOLD Executive Committee[DB/OL].Guidelines:Global Strategy for Diagnosis,Management,and Prevention of COPD,November 2006[2006-11-18].http://www.goldcopd.com/Guidelineitem.asp? l1 =2-12 = 1&intId =989.
4Celli BR,MacNee W,Committee members.Standard for the diagnosis and treatment of patients with COPD:a summary of the ATS/ERS position paper.Eur Respir J,2004,23:932-946.
5Celli BR,Cote CG,Marin JM,ct al.The body mass index,airflow obstruction,dyspnea and exercise capacity index in chronic obstructive pulmonary disease.N Engl J Med,2004,350:1005-1012.
7Angshu BH,Terence AKS,Rajmone JS,et al.Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations[J].Thorax,2000,55:114-120
8Crooks SW,Bayley DL,Hill SL,et al.Bronchial inflammaition in acute bacterial exacerbations of chronic bronchitis:the role of leukotriene B4[J].Eur Respir,2000,15:274-280
9Biernacki WA,kharitonov SA,Barnes PJ.Increased leukotriene B4 and-8isoprostane in exhaled breath condensate of patients with acute exacerbation of COPD[J].Thorax,2003,58:294 -298
